Vivos (RDGL) Other Non-Current Assets (2010 - 2025)

Vivos' (RDGL) quarterly Other Non-Current Assets came in at $113703.0 in Q4 2025, up 16895.96% quarter-over-quarter from $669.0 in Q3 2018.

Analysis

Vivos (RDGL) Other Non-Current Assets (2010 - 2025) Analysis & Trends

Vivos has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $113703.0 for Q4 2025.

In Q4 2025, Other Non-Current Assets changed N/A year-over-year to $113703.0; the TTM figure through Dec 2025 stood at $113703.0 (changed N/A YoY), while the FY2025 annual figure was $113703.0, changed N/A from the prior year.
Other Non-Current Assets came in at $113703.0 for Q4 2025 at Vivos, up from $669.0 in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $113703.0 in Q4 2025 to a low of $113703.0 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	-
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	4.32 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	3.23 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	45.22 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	616.40 Mn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	434.00 Mn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	273.70 Mn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	215.10 Mn
10	Vivos	23.21 Mn	23.21 Mn	-	-

Historic Data

Download Data